Vimarsana
Biggest News Aggregation in the World

Page 11 - Gregory Bailey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gregory Bailey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gregory Bailey Today - Breaking & Trending Today

Caribbean Agriculture Ministers Discuss New Challenges Stemming from the COVID-19 Pandemic - Vimarsana News

Caribbean Agriculture Ministers Discuss New Challenges Stemming from the COVID-19 Pandemic

Caribbean Agriculture Ministers Discuss New Challenges Stemming from the COVID-19 Pandemic Sponsored and secret aries of agriculture of 14 Caribbean countries related some of the dramatic consequences of the COVID-19 pandemic in the region. They listed new challenges in strengthening food production and emphasized the support that the Inter-American Institute for Cooperation on Agriculture (IICA) provided in the fight against food and nutritional insecurity in 2020 – a year that had crippled tourism, the engine, of Caribbean economies. The ministers and secretaries were participating in IIC...

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing - Vimarsana News

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing News provided by Share this article Share this article PITTSBURGH, Dec. 30, 2020 /PRNewswire/ -- LyGenesis, Inc., a biotechnology company developing cell therapies that enable organ regeneration, announced today that the U.S Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application. Under the IND, LyGenesis will be conducting a Phase 2a study on the safety, tolerability, and efficacy...